RxDoctor Payments Data

Ronald Paasch, MD

Physical Medicine & Rehabilitation · West Springfield, MANPI 1609834670

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 28.3% of the total. Reporting peaked in 2019 at $565 and has fallen 63.2% since, to $208 in 2025.

$1,497in general payments, 2019–2025

Across 78 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$423
  • Assertio Therapeutics, Inc.$155
  • Collegium Pharmaceutical, Inc.$97
  • Fidia Pharma USA Inc.$80
  • Painteq LLC$71
  • Medtronic$70
  • plus $602 from 21 others

What the payments were for

  • Food & beverage$1,497100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,497 in reported general payments places this provider in the 80th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.

See all physical medicine & rehabilitation providers in Massachusetts

Medicare billing

Part B allowed, 2024
$180,672
Medicare patients
752
Services billed
15,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl26$12,098
Celecoxib252$4,347
Pregabalin264$3,504
Lidocaine24$2,666
Gabapentin152$1,964
Fentanyl20$1,170
Meloxicam176$1,006
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$953
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen34$863
Tramadol Hcl130$681
Oxycodone Hcl32$653
Baclofen21$620
Tizanidine Hcl29$509
Cyclobenzaprine Hcl46$468
Morphine Sulfate ErMorphine Sulfate18$415

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in West Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →